The driving force for new, targeted clinical therapies for pancreatic cancer patients.

Antoine Adenis
Antoine Adenis, MD
Oscar Lambret Centre
Mitesh Borad
Mitesh Borad, MD
Mayo Clinic Arizona
Vincent Chung
Vincent Chung, MD
City of Hope National Medical Center
Steven Cohen
Steven Cohen, MD
Fox Chase Cancer Center
Arkadiusz  Dudek
Arkadiusz Dudek, MD, PhD
University of Illinois at Chicago
Charles Henderson
Charles Henderson, MD
Piedmont Healthcare Research Institute
Manuel Hidalgo
Manuel Hidalgo, MD, PhD
Centro Nacional de Investigaciones Oncologicas
Daniel Laheru
Daniel Laheru, MD
Johns Hopkins University
Noelle LoConte
Noelle LoConte, MD
University of Wisconsin
Wen Ma
Wen Ma, MD
Roswell Park Cancer Institute
Teresa Macarulla
Teresa Macarulla, MD
Vall d'Hebron
Heyoung McBride
Heyoung McBride, MD
Arizona Oncology Services
James Moser
James Moser, MD
Beth Israel Deaconess-Harvard
Francis Nugent
Francis Nugent, MD
Lahey Clinic
Vincent Picozzi
Vincent Picozzi, MD
Virginia Mason Cancer Center
Ramesh Ramanathan
Ramesh Ramanathan, MD
Mayo Clinic Arizona
Donald Richards
Donald Richards, MD, PhD
Texas Oncology
John Seng
John Seng, MD
Virginia G. Piper Cancer Institute
Darren Sigal
Darren Sigal, MD
Scripps Research Institute
Keith Stuart
Keith Stuart, MD
Lahey Clinic
Josep Tabernero
Josep Tabernero, MD
Vall d'Hebron
Daniel Von Hoff
Daniel Von Hoff, MD, FACP
Scottsdale Healthcare
Herbert Zeh
Herbert Zeh, MD
University of Pittsburgh Medical Center
Stephen Anthony
Stephen Anthony, DO
Evergreen Hematology & Oncology
Nathan Bahary
Nathan Bahary, MD, PhD
University of Pittsburgh Medical Center
Fay Chi Lee
Fay Chi Lee, MD
New Mexico Care Alliance
Shubham Pant
Shubham Pant, MD
University of Oklahoma
Paul Ritch
Paul Ritch, MD
Medical College of Wisconsin
Timothy Sielaff
Timothy Sielaff, MD, PhD, FACS
Virginia G. Piper Cancer Institute
Lon Smith
Lon Smith, MD
South Texas Oncology and Hematology
Selwyn Vickers
Selwyn Vickers, MD
University of Minnesota
Colin Weekes
Colin Weekes, MD, PhD
University of Colorado Cancer Center
Carlos Gomez-Martin
Carlos Gomez-Martin, MD
Centro Nacional de Investigaciones Oncologicas
Wells Messersmith
Wells Messersmith, MD
University of Colorado Cancer Center
Allyson Ocean
Allyson Ocean, MD
Cornell University Weill Medical College
Venu Bathini
Venu Bathini, MD
University of Massachusetts
Gabriela Chiorean
Gabriela Chiorean, MD
Indiana University Simon Cancer Center
Laurence McCahill
Laurence McCahill, MD
Saint Mary's Healthcare Lacks Cancer Center
M. Wasif Saif
M. Wasif Saif, MD
Tufts University
Anna Niewiarowska
Anna Niewiarowska, MD
Vita Medical Associates
Jean-Frederic Sauniere
Jean-Frederic Sauniere, MD, PhD
Institut Paoli-Calmettes
Sunil Hingorani
Sunil Hingorani, MD
Fred Hutchinson Cancer Research Center
Andrea  Bullock
Andrea Bullock, MD
Beth Israel Deaconess-Harvard
Tom Dragovich
Tom Dragovich, MD, PhD
Banner MD Anderson Cancer Center
Anthony Goncalves
Anthony Goncalves, MD, PhD
Institut Paoli-Calmettes
Edward Greeno
Edward Greeno, MD
University of Minnesota
Thomas  Gribbin
Thomas Gribbin, MD
Saint Mary's Healthcare Lacks Cancer Center
Madappa Kundranda
Madappa Kundranda, MD, PhD
CTCA-Western Regional Medical Center
Joseph Leach
Joseph Leach, MD
Virginia G. Piper Cancer Institute
Asha Dharanajan
Asha Dharanajan, MD
Loyola University
Ray McDermott
Ray McDermott, MD, PhD
Tallaght Hospital and St. Vincents University Hospital
Eyal Mieri
Eyal Mieri, MD
CTCA-SOuthEastern Regional Medical Center
Rebecca Miksad
Rebecca Miksad, MD
Beth Israel Deaconess-Harvard
Monica  Mita
Monica Mita, MD
Cedars Sinai Medical Center
Andrew  Hendifar
Andrew Hendifar, MD
Cedars Sinai Medical Center
Elizabeth Poplin
Elizabeth Poplin, MD
Rutgers/Cancer Institute of New Jersey
Safi Shahda
Safi Shahda, MD
Indiana University Simon Cancer Center
Mark O'Rourke
Mark O'Rourke, MD
Cancer Center of the Carolinas
Andrea  Wang-Gillam
Andrea Wang-Gillam, MD, PhD
Washington University
Raul Mena
Raul Mena, MD
Disney Family Cancer Center - Providence St. Joseph

The Pancreatic Cancer Research Team (PCRT) is a multi-disciplined group of preeminent researchers dedicated to organizing and accelerating the clinical development of new agents for the treatment of patients with pancreatic cancer.

PCRT's members include laboratory and clinical researchers who share the passion to bring new advances to patients with pancreatic cancer as rapidly as possible providing the only coordinated effort in the world dedicated to rapidly translating research discoveries into new treatments and supportive care... Click here to learn more